L18V (p.Leu18Val) variant of SGCA (Alpha-sarcoglycan)

L18V (p.Leu18Val) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Autosomal recessive limb-girdle muscular dystrophy type 2D. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes structural context.

L18V (p.Leu18Val) variant details